Product
Foscarnet
1 clinical trial
2 indications
Indication
Cytomegalovirus InfectionsIndication
Hematological DisorderClinical trial
Cytomegalovirus Specific Cytotoxic T Lymphocyte for the Treatment of Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2021-12-31